Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study. Iv Bionda C, Bergerot C, Ardail D, Rodriguez-Lafrasse C, Rousson R. Natriuretic Peptides in Congestive Heart Failure.
Generating Evidence, Guiding Policy Report The Global Burden of Diseases, Injuries and Risk Factors Study 2010 (GBD 2010). Ii Institute for Health Metrics and Evaluation (IHME). Retrieved May 27, 2021, from Who.int website:
in the United States and other countries. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc.
Beckman coulter brea update#
These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, we not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise. Information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher Corporation's SEC filings, including Danaher's 2020 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the second quarter of 2021. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Statements in this release that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future, are "forward-looking" statements within the meaning of the federal securities laws. is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place. A subsidiary of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter, Inc. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Learn more about Beckman Coulter's cardiovascular disease solutions at About Beckman Coulterīeckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Anagh Vora, chief medical officer, Beckman Coulter. This is an important biomarker in the diagnosis of heart failure (HF) and left ventricular dysfunction," said Dr. "BNP is a protein secreted by the ventricular musculature in response to volume or pressure overload on the heart. The speed and accuracy of the information a clinical laboratory delivers are critical to improving patient outcomes and reducing the cost of care. Clinical laboratories can support care for patients experiencing, or at risk for, cardiovascular disease. The cost of CVDs globally is estimated to rise to $1 trillion USD by 2030. Four out of five CVD deaths are due to heart attacks and strokes, while one third of these deaths occur prematurely in people under 70 years of age. Our panel of CVD assays supports advancing care for cardiac patients."Ĭardiovascular diseases account for an estimated 31% of all deaths worldwide and are the number one cause of death, globally killing ~17.9 million people each year. "Successful management of CVD means reducing the risk of adverse events by making the right decisions quickly. "We are excited to add Access BNP to Beckman Coulter's line of high-quality cardiac assays and provide a streamlined customer experience for our many customers that use this critical assay," said Julie Sawyer Montgomery, president, Beckman Coulter.
0 kommentar(er)
